Accessibility Menu
NuVasive logo

NuVasive(NASDAQ) NUVA

This security has been delisted. This page is retained for historical reference.

NuVasive last closing stock price
MetricPriceDate
Last closeUSD 39.752023-08-31
NuVasive stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.28%USD 38.122023-08-24
1 month-2.67%USD 40.842023-08-01
3 month+0.84%USD 39.422023-06-02
Year to date-3.61%USD 41.242022-12-30
1 year-6.49%USD 42.512022-08-31
3 year-23.75%USD 52.132020-08-31
5 year-43.37%USD 70.192018-08-31
Since inception+248.68%USD 11.402004-05-13

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

NUVA Financials

Key Financial Metrics (TTM)

Gross Margin

72.00%

Operating Margin

5.39%

Net Income Margin

3.36%

Return on Equity

4.86%

Return on Capital

3.45%

Return on Assets

1.82%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$878.73M

Operating Income

$82.43M

EBITDA

$163.96M

Operating Cash Flow

$139.51M

Capital Expenditure

-$142.84M

Free Cash Flow

-$3.33M

Cash & ST Invst.

$80.72M

Total Debt

$906.15M

NuVasive Performance Analysis

NuVasive annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 1,138,988,000N/A
20222022-12-31USD 1,201,942,0005.5%
NuVasive sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-30-4.9%
Q42022-12-313.4%
Q12023-03-310.7%
Q22023-06-303.3%
NuVasive annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -1.24N/A
20222022-12-31USD 0.70N/A
NuVasive sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-30-120.9%
Q42022-12-311205.3%
Q12023-03-31-104.6%
Q22023-06-30821.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$317.79M

+2.4%

Gross Profit

$228.31M

+1.6%

Gross Margin

71.84%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

3,000

N/A

Net Income

$7.36M

+924.6%

EBITDA

$51.41M

+58.1%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Total Cash

$80.72M

-64.3%

Total Debt

$906.15M

-9.9%

Accounts Receivable

$267.11M

+14.4%

Inventory

$350.81M

+5.8%

Long Term Debt

$545.36M

-0.8%

Short Term Debt

$360.79M

-20.9%

Return on Assets

1.82%

N/A

Return on Invested Capital

4.29%

N/A

Free Cash Flow

-$495.00K

-101.9%

Operating Cash Flow

$36.52M

-40.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASTHAstrana Health, Inc.
$40.31-1.66%
CALTCalliditas Therapeutics AB (publ)
$40.00-0.10%
DCPHDeciphera Pharmaceuticals, Inc.
$25.59+0.08%
DICEDICE Therapeutics, Inc.
$47.55+0.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.